Skip to main content
Premium Trial:

Request an Annual Quote

Anthony Recupero Joins MaxCyte from Gene Logic; Karen Gibson, Nicolas Barthelemy New Senior VP s of Invitrogen; Rudolph Potenzone Joins Ingenuity as Senior VP; and Others

Anthony Recupero has joined MaxCyte as vice president for business development, the Rockville, Md.-based company said yesterday. He is the former senior director for business development at Gene Logic. Recupero holds a PhD in molecular and cell biology from the University of Cincinnati.


Karen Gibson has become senior vice president of information technology and chief information officer, and Nicolas Barthelemy senior vice president of global operations of Invitrogen, the company said last week.


Most recently, Gibson was vice president of global e-business and chief information officer at General Electric's Medical Systems Information Technologies division. She holds an MBA from Ohio University and a BS in computer technology from Purdue University.


Barthelemy joins Invitrogen from Biogen, where he was vice president of manufacturing and general manager of the company's Research Triangle Park site. He holds a degree in mathematics, physics and chemistry from the Ecole Superieure de Physiques et Chimie Industrielles in France, and a master's of science in chemical engineering from the University of California at Berkeley.


Rudolph Potenzone has become senior vice president of business development and strategic planning at Ingenuity, the company said last week. Prior to joining Ingenuity, he was the CEO of Lion Bioscience's US subsidiary. Potenzone holds a PhD in macromolecular science from Case Western Reserve University and a bachelor of science in biophysics and microbiology from the University of Pittsburgh.


Alan Finkel, CEO of Axon Instruments, is expected to become vice president and chief technology officer of Molecular Devices after Molecular's acquisition of Axon, Molecular Devices said on Sunday.


Following the acquisition, Geoffrey Powell will retire as president of Axon.


Patty Fish will become vice president for human resources at Sigma-Aldrich next month, the company said last week. She joins the company from RehabCare, where she was senior vice president for human resources, training, and education. Fish holds a master's degree from the George Warren Brown School of Social Work at Washington University in St. Louis and a bachelor's degree in education from Kent State University.


Michael Avallone has been promoted to CFO, from corporate controller, of Boston Biomedica, the West Bridgewater, Mass.-based company said last week.


Claudio Quarta has stepped down as chief operating officer of Vicuron Pharmaceuticals "to pursue other opportunities," the company said last week.


Cheryl Moore has become associate director and chief operating officer of Howard Hughes Medical Institute's new Janelia Farm Research Campus, which is scheduled to open in 2006, HHMI said last week. She comes to HHMI from the Burnham Institute, where she was senior vice president, chief operating officer, and chief administrative officer. She is a graduate of the University of San Diego.


Dennis Langer has been elected to the board of directors of Myriad Genetics, the company said yesterday. He is a clinical professor at the department of psychiatry at Georgetown University School of Medicine and the president for North America at Dr. Reddy's Laboratories, which is based in India. Prior to that, he was senior vice president for project and portfolio management, research, and development at GlaxoSmithKline. Langer holds a JD from Harvard Law School and an MD from Georgetown University School of Medicine, as well as a BA in biology from Columbia University.


Donald Steen has been elected to the board of directors of AmeriPath, where he will serve as chairman, the company said on Monday. He is the chairman of United Surgical Partners, a company he founded. Steen replaces Paul Queally, who has been elected chairman of the executive committee.


Anthony Cavalieri has joined the board of directors of Chromatin, the company said last week. He recently retired as vice president for trait and technology development at Pioneer Hi-Bred, where he helped establish the company's strategy in genomics, including the formation of research collaborations with genomics companies.


Craig Mello has joined the scientific advisory board of CytRx and its subsidiary, Araios, the company said last week. He is a professor of molecular medicine and a Howard Hughes investigator at the University of Massachusetts Medical School. Mello received a PhD from Harvard University and a ScB from Brown University.


Brian Beatty has been appointed to the scientific/educational advisory board of San Francisco electronic teaching firm GeneEd, the company said on Monday. He is an assistant professor in the instructional technology department at San Francisco State University, where he leads an e-learning program. Beatty holds a PhD in instructional systems technology from Indiana University Bloomington and an MA in instructional technologies from San Francisco State University, as well as a BS in electrical engineering from Marquette University.


Frederick Alt has won the 2004 Clowes Memorial Award from the American Association of Cancer Research, the organization said yesterday. He is a senior investigator at the CBR Institute for Biomedical Research in Boston, a Howard Hughes investigator at Children's Hospital Boston, and a professor of pediatrics at Harvard Medical School. Alt, who will receive the award at the AACR's annual meeting in Orlando, Fla. next week, is honored for his work investigating genomic stability and its role in the development of cancer.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.